Anticholinergics aggravate the imbalance of the autonomic nervous system in stable chronic obstructive pulmonary disease
Autor: | Nan Jia, Shan Nie, Qiufen Xu, Haoyan Wang, Wei Yuan |
---|---|
Rok vydání: | 2019 |
Předmět: |
Male
Pulmonary and Respiratory Medicine Cardiac function curve medicine.medical_specialty Pulmonary disease Autonomic Nervous System Cholinergic Antagonists Pulmonary Disease Chronic Obstructive 03 medical and health sciences 0302 clinical medicine Heart Rate Internal medicine Administration Inhalation Heart rate Humans Medicine In patient Prospective Studies 030212 general & internal medicine Tiotropium Bromide Autonomic nervous imbalance Aged Peak exercise lcsh:RC705-779 COPD business.industry Chronic obstructive pulmonary disease lcsh:Diseases of the respiratory system Middle Aged medicine.disease Bronchodilator Agents Respiratory Function Tests respiratory tract diseases Autonomic nervous system Heart rate recovery Increased risk 030228 respiratory system Cardiovascular Diseases Multivariate Analysis Exercise Test Cardiology Regression Analysis Female business human activities Anticholinergics Research Article |
Zdroj: | BMC Pulmonary Medicine BMC Pulmonary Medicine, Vol 19, Iss 1, Pp 1-6 (2019) |
ISSN: | 1471-2466 |
Popis: | Background Inhaled anticholinergics, recommended as first-line maintenance treatment for patients with moderate-to-severe chronic obstructive pulmonary disease (COPD), has been demonstrated to be associated with an increased risk of cardiovascular diseases. Nevertheless, why COPD patients using inhaled anticholinergics have this higher risk remains unknown. One of mechanisms may be an autonomic imbalance because anticholinergics yield reduced vagal nervous activity. To test our hypothesis, we studied heart rate recovery (HRR) after exercise, recognized as a marker of cardiac autonomic function, in COPD patients using and not using inhaled anticholinergics. Methods Sixty patients with COPD were involved in this study (mean FEV1 = 1.57 ± 0.42 L), including 24 patients who had received tiotropium for more than 1 year and 36 patients not using tiotropium as a control group. A maximal cardiopulmonary exercise test was performed. HRR was defined as the difference between peak exercise and at 1-min recovery heart rate. Results HRR was significantly lower in patients using tiotropium than in the controls (16 ± 6 vs 22 ± 8 beats/min, respectively, p |
Databáze: | OpenAIRE |
Externí odkaz: |